Kenneth P. Olive
Columbia University in the City of New York
H-index: 35
North America-United States
Top articles of Kenneth P. Olive
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Disrupting local immunosuppression by combined myCAF/myeloid targeting in pancreatic cancer | Cancer Research | Marie C Hasselluhn Dafydd Thomas Lukas Vlahos Alvaro Curiel-Garcia Amanda R Decker-Farrell | 2024/3/22 |
Abstract PR05: CheMo4METPANC: Combination Chemotherapy (gemcitabine and nab-paclitaxel), chemokine (CXC) Motif receptor 4 inhibitor (motixafortide), and immune checkpoint … | Cancer Research | Gulam A Manji Michael May Morteza Hajkarim Chalabi Ilenia Pellicciotta Sarah I Sta Ana | 2024/1/16 |
Addressing Biological Questions with Preclinical Cancer Imaging | Chris B Damoci Joseph R Merrill Yanping Sun Scott K Lyons Kenneth P Olive | 2024/3/19 | |
Adaptive heterogeneity enables the survival of residual malignant PDAC cells in response to RAS-GTP inhibition | Cancer Research | Lorenzo Tomassoni Urszula N Wasko Alvaro C Garcia Tanner C Dalton Pasquale Laise | 2024/3/22 |
Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression | Cancer Discovery | Marie C Hasselluhn Amanda R Decker-Farrell Lukas Vlahos Dafydd H Thomas Alvaro Curiel-Garcia | 2024/2/8 |
RAS-GTP inhibition modulates Hedgehog signaling, suppressing myCAFs and promoting iCAFs in pancreatic ductal adenocarcinoma | Cancer Research | Marie Hasselluhn Lorenzo Tomassoni Urszula Wasko Alvaro Curiel-Garcia Tanner Dalton | 2024/3/22 |
An NFATc1/SMAD3/cJUN complex restricted to SMAD4-deficient pancreatic cancer guides rational therapies | Gastroenterology | Marie C Hasselluhn Denise Schlösser Lennart Versemann Geske E Schmidt Maria Ulisse | 2024/2/1 |
RNA-based precision medicine predicts sensitivity to selinexor in select pancreatic ductal adenocarcinoma patients | Cancer Research | Alvaro Curiel-Garcia Lorenzo Tomassoni Tanner C Dalton Amanda R Decker-Farrell Carmine F Palermo | 2024/3/22 |
Abstract B101: Tumor-selective inhibition of active RAS in pancreatic ductal adenocarcinoma | Cancer Research | Urszula N Wasko Jingjing Jiang Lorenzo Tomassoni Yingyun Wang Bianca Lee | 2024/1/16 |
Tumor-selective activity of RAS-GTP inhibition in pancreatic cancer | Nature | Urszula N Wasko Jingjing Jiang Tanner C Dalton Alvaro Curiel-Garcia A Cole Edwards | 2024/4/8 |
Abstract B015: Toxin-producing bacterial therapy limits tumor growth in autochthonous mouse models of pancreatic ductal adenocarcinoma | Cancer Research | Amanda R Decker-Farrell Stephen A Sastra Tetsuhiro Harimoto Marie C Hasselluhn Fangda Li | 2024/1/16 |
Resistance to RAS-GTP inhibition in models of pancreatic ductal adenocarcinoma arises downstream of RAS effectors | Cancer Research | Urszula N Wasko Jingjing Jiang Tanner C Dalton Alvaro Curiel-Garcia A Cole Edwards | 2024/3/22 |
Ras-dependent activation of BMAL2 regulates hypoxic metabolism in pancreatic cancer | bioRxiv | H Carlo Maurer Alvaro Curiel-Garcia Sam Holmstrom Pasquale Laise Carmine F Palermo | 2023/3/21 |
A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies | Cancer discovery | Prabhjot S Mundi Filemon S Dela Cruz Adina Grunn Daniel Diolaiti Audrey Mauguen | 2023/6/2 |
Pervasiveness of HLA allele-specific expression loss across tumor types | Genome Medicine | Ioan Filip Anqi Wang Oleksandr Kravets Rose Orenbuch Junfei Zhao | 2023/2/9 |
Generation and ex vivo culture of murine and human pancreatic ductal adenocarcinoma tissue slice explants | Star Protocols | Amanda R Decker-Farrell Alice Ma Fangda Li Alexander Muir Kenneth P Olive | 2023/12/15 |
Comprehensive DNA methylation analysis indicates that pancreatic intraepithelial neoplasia lesions are acinar-derived and epigenetically primed for carcinogenesis | Cancer research | Emily KW Lo Brian M Mears H Carlo Maurer Adrian Idrizi Kasper D Hansen | 2023/6/2 |
Pharmacological targeting of the receptor ALK inhibits tumorigenicity and overcomes chemoresistance in pancreatic ductal adenocarcinoma | Biomedicine & Pharmacotherapy | Beatriz Parejo-Alonso Alba Royo-García Pilar Espiau-Romera Sarah Courtois Álvaro Curiel-García | 2023/2/1 |
BMAL2 is a KRAS-dependent master regulator of hypoxic response in pancreatic ductal adenocarcinoma | Cancer Research | Alvaro Curiel Garcia Carlo H Maurer Kate Hollinshead Pasquale Laise Anthony Andren | 2023/4/4 |
Tumor-selective effects of active RAS inhibition in pancreatic ductal adenocarcinoma | bioRxiv | Urszula N Wasko Jingjing Jiang Alvaro Curiel-Garcia Yingyun Wang Bianca Lee | 2023/12/4 |
